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• Lung transplantation is the last therapeutic option for end-stage pulmonary failure. Yet, clinical complications may rise after 
transplantation, such as primary grafts dysfunction (PGD) or chronic lung allograft dysfunction (CLAD). Current clinical 
parameters have failed to assess the quality of the graft and to predict transplantation outcome.
• Extracorporeal photopheresis (ECP) is a treatment for graft-versus-host disease. Peripheral blood white blood cells (WBC) are 
isolated, exposed to 8-methoxypsoralen photosensitizing agent, and subsequently treated with ultraviolet radiation before 
reinfusion into the patient, causing massive WBC apoptosis.
Our working hypothesis is that extracellular vesicles (EV) produced by either the pre-transplantation organ (donor) or host
(recipient) could be non-invasive biomarkers to evaluate tissue damage at the cellular level and to monitor organ engraftment. 
Two cohorts of patients receiving (n=10) or not (n=10) ECP are currently being enrolled in the study. Study schematic:
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Particle samples will be analyzed for RNA content and antigen expression to define EV identity, upon correlation with lung 
transplantation outcome that will be evaluated at the conclusion of the study. For the time being, no PGD or CLAD were observed. 
The identification of specific EV kinetics patterns and RNA signatures represents a promising approach to define biomarkers useful 
for thoracic surgeons who want to manage in advance complications associated to lung transplantation.
Preliminary results showed presence of particles of different sizes in bronchoalveolar lavage (BAL) and plasma of both donors (n=3) 
and recipients (n=3), as analyzed by nanoparticle tracking analysis (Nanosight NS300, Malvern). The particles showed highly 
polydispersed size distributions in a 50-1000 nm range. Different kinetics of particle production were observed in the recipients: both 
BAL and plasma samples showed lower particle concentration after ECP (T2). At the end of the study normalization on pre-ECP 
values will be carefully evaluated to remove any recipient-related bias. 
Contacts: Mario Barilani, mario.barilani@policlinico.mi.it (EV characterization)
Lorenzo Rosso, lorenzo.rosso@unimi.it (lung transplantation)
Ilaria Righi, ilaria.righi@policlinico.mi.it (lung transplantation, photopheresis)
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Mean particle
size (nm) ECP Control
BAL T1
recipient 224 ± 25 226 ± 53
BAL T2
recipient 220 ± 60 251 ± 37
PLASMA T1 
recipient 128 ± 36 106 ± 33
PLASMA T2 
recipient 159 ± 43 153 ± 39
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Figure 1: Histograms showing particle 
concentration in donor BAL (A) and plasma (B) 
before organ transplantation.
Figure 2: Table reporting mean size of 
detected particles in recipients at T1 and T2 
(A). Histograms showing particle concentration 
in recipient BAL (B) and plasma (C) before (T1) 
and after (T2) ECP.
All data are presented as mean ± standard 
deviation.
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